Laura Jones, Ph.D., has been appointed vice president of quality and regulatory affairs at Avrio Biopharmaceuticals. Dr. Jones will be responsible for leading and overseeing Avrio’s quality and regulatory compliance systems.   “With more than 25 years of experience in the pharmaceutical and biopharmaceutical industries, Laura offers a wealth of knowledge and experience in quality assurance and regulatory affairs,” said William Botha, president of Avrio Biopharma. “I am confident knowing that Lau...